Progressive brain dysfunction following intracerebroventricular infusion of beta1–42-amyloid peptide
- 7 September 2001
- journal article
- Published by Elsevier in Brain Research
- Vol. 912 (2) , 128-136
- https://doi.org/10.1016/s0006-8993(01)02704-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Delayed behavioral effects following intrahippocampal injection of aggregated Aβ(1–42)Brain Research, 1999
- Nontoxic Amyloid β Peptide1-42 Suppresses Acetylcholine SynthesisPublished by Elsevier ,1997
- Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic?Neurobiology of Aging, 1992
- Implants containing β-amyloid protein are not neurotoxic to young and old rat brainNeurobiology of Aging, 1992
- Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortexNeurobiology of Aging, 1992
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Identification of Sodium‐Dependent, High‐Affinity Choline Uptake Sites in Rat Brain with [3H]Hemicholinium‐3Journal of Neurochemistry, 1986
- Spatial localization does not require the presence of local cuesLearning and Motivation, 1981
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976